News

Search Articles

76 - 86 of 86 Results Clear All

December 18, 2013

Gladstone Scientists Discover How Key Immune Cells Die During HIV Infection and Identify Potential Drug to Block AIDS

SAN FRANCISCO, CA—Research led by scientists at the Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS.

Greene Lab Infectious Disease HIV/AIDS

December 17, 2013

No Link Between HIV-Prevention Pill Truvada and Increased Sexual Risk Behavior, Gladstone-Led Study Finds

SAN FRANCISCO, CA—In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.

Grant Lab Infectious Disease HIV/AIDS

October 29, 2013

Gladstone Scientists Identify Molecular Signals that Rouse Dormant HIV Infection

SAN FRANCISCO, CA—Perhaps the single greatest barrier to curbing the spread of HIV/AIDS is the dormant, or “latent,” reservoir of virus, which is out of reach of even the most potent medications.

Greene Lab Infectious Disease HIV/AIDS

Article September 29, 2013

Gladstone Scientists Win $12.5M in Prestigious Grant Awards

SAN FRANCISCO, CA—Three Gladstone scientists have won research awards from divisions of the National Institutes of Health (NIH) equaling an approximate total of $12.5 million over five years for their groundbreaking research to overcome HIV/AIDS.

HIV/AIDS Infectious Disease Greene Lab Sanjabi Lab Weinberger Lab

September 11, 2012

Gladstone-Led Study Underscores Truvada’s Potency in Preventing the Transmission of HIV

SAN FRANCISCO, CA—New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada—the first and only medication approved by the FDA for HIV prevention.

Grant Lab HIV/AIDS

September 10, 2012

Gladstone Scientists Develop Innovative Technique to Monitor and Decipher the Dormant AIDS Virus Concealed in Cells

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

HIV/AIDS Weinberger Lab

December 20, 2011

Gladstone and UCSF Scientists Provide a Global View of How HIV/AIDS Hijacks Cells During Infection

SAN FRANCISCO, CA—Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV—the virus that causes AIDS—hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.

HIV/AIDS Krogan Lab

Gladstone in the News December 16, 2010

Gladstone-Led HIV Study Tops Time List

San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.

Gladstone Experts HIV/AIDS

November 23, 2010

Deciphering How CD4 T Cells Die During HIV Infection

SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.

Greene Lab HIV/AIDS

November 22, 2010

Use of HIV Medications Reduces Risk of HIV Infection in Uninfected People

San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov

Grant Lab HIV/AIDS

January 3, 2010

Gladstone Scientists Identify Agent That May Inhibit HIV Infectivity

SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.

Greene Lab HIV/AIDS

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media

Are You a Journalist Looking to Write about Gladstone?

Sign Up for Our Newsletter

Congrats to Jennifer Doudna, winner of the 2020 Nobel Prize in Chemistry!